Safety of trastuzumab (Herceptin) during pregnancy: two case reports
- PMID: 20062589
- PMCID: PMC2803989
- DOI: 10.1186/1757-1626-2-9329
Safety of trastuzumab (Herceptin) during pregnancy: two case reports
Abstract
We report on two cases of women on trastuzumab therapy for breast cancer who became pregnant and delivered healthy live infants. At the time of reporting the children are growing and developing normally (ages 3 and 2).
Similar articles
-
Trastuzumab in the treatment of advanced breast cancer: single-center experience.Ann Oncol. 2001;12 Suppl 1:S95-6. doi: 10.1093/annonc/12.suppl_1.s95. Ann Oncol. 2001. PMID: 11521730
-
Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group.Semin Oncol. 1999 Aug;26(4 Suppl 12):71-7. Semin Oncol. 1999. PMID: 10482196 Review.
-
MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells.Breast Cancer Res Treat. 2009 Nov;118(1):113-24. doi: 10.1007/s10549-009-0412-3. Epub 2009 May 5. Breast Cancer Res Treat. 2009. PMID: 19415485
-
Efficacy and safety of Herceptin in women with metastatic breast cancer: results from pivotal clinical studies.Anticancer Drugs. 2001 Dec;12 Suppl 4:S3-10. doi: 10.1097/00001813-200112004-00002. Anticancer Drugs. 2001. PMID: 11989525 Review.
-
Kinetic Modeling of DUSP Regulation in Herceptin-Resistant HER2-Positive Breast Cancer.Genes (Basel). 2019 Jul 26;10(8):568. doi: 10.3390/genes10080568. Genes (Basel). 2019. PMID: 31357550 Free PMC article.
Cited by
-
Breast cancer and pregnancy: current concepts in diagnosis and treatment.Oncologist. 2010;15(12):1238-47. doi: 10.1634/theoncologist.2010-0262. Epub 2010 Dec 8. Oncologist. 2010. PMID: 21147871 Free PMC article. Review.
-
Challenges in managing breast cancer during pregnancy.J Thorac Dis. 2013 Jun;5 Suppl 1(Suppl 1):S62-7. doi: 10.3978/j.issn.2072-1439.2013.05.21. J Thorac Dis. 2013. PMID: 23819029 Free PMC article.
-
Is chemotherapy always required for cancer in pregnancy? An observational study.Ir J Med Sci. 2017 Nov;186(4):875-881. doi: 10.1007/s11845-017-1602-3. Epub 2017 May 5. Ir J Med Sci. 2017. PMID: 28477329
-
Current approaches in the clinical management of pregnancy-associated breast cancer-pros and cons.EPMA J. 2018 Jun 24;9(3):257-270. doi: 10.1007/s13167-018-0139-5. eCollection 2018 Sep. EPMA J. 2018. PMID: 30174762 Free PMC article. Review.
-
Cancer Treatment and Immunotherapy during Pregnancy.Pharmaceutics. 2022 Sep 29;14(10):2080. doi: 10.3390/pharmaceutics14102080. Pharmaceutics. 2022. PMID: 36297515 Free PMC article. Review.
References
-
- Friedrichs B, Tiemann M, Salwender H, Verpoort K, Wenger MK, Schmitz N. The effects of rituximab treatment during pregnancy on a neonate. Haematologica. 2006;91:1426–7. cited by Mir O, Berveiller P, Pons G: Trastuzumab - mechanism of action and use. N Engl J Med 2007, 357(16):1664-5. - PubMed
-
- Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinksy MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4:1255–8. doi: 10.1016/j.cgh.2006.07.018. cited by Mir O, Berveiller P, Pons G: Trastuzumab - mechanism of action and use. N Engl J Med 2007, 357(16):1664-5. - DOI - PubMed
-
- Watson WJ. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstetrics and Gynecology. 2005;105(3):642–3. - PubMed
LinkOut - more resources
Full Text Sources